Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year

1. Moncada, E.
2. Subirá, M.L.
3. Oleaga, A.
4. Goñi, F.
5. Sánchez-Ibarrola, A.
6. Monreal, M.
7. Sevilla, M.
8. Goñi, M.J.
9. Yoldi, A.
10. Terán, D.
11. Llorente, I.